Consensus Akeso, Inc.

Equities

9926

KYG0146B1032

Biotechnology & Medical Research

Market Closed - Hong Kong S.E. Other stock markets 01:38:20 13/03/2026 pm IST			5-day change	1st Jan Change
110.20 ^HKD	-0.81%		+2.70%	-2.48%

05/03	Nomura Adjusts Akeso's Price Target to HK$112.73 From HK$120.64, Keeps at Neutral	MT
05/03	Akeso, Inc. Presents Long-Term Phase II Results For Cadonilimab In Recurrent Or Metastatic Cervical Cancer	CI

Evolution of the Average Target: Akeso, Inc.

Evolution of the Target Price: Akeso, Inc.

Changes in Analyst Recommendations: Akeso, Inc.

62efabd1ea8.av76Oe7hP1l1CsHtVnHZqURlZohynzSw7AoneABWh0E.BLKsSa2bZW8HbPKcHRWt7w4QL-sDyWDlvkN9GU5n5ic7vZJLgMxoKRJ_lA~2a5e790920420cc718edb33ca928a62a

Analysts' recommendations: Akeso, Inc.

05/03	Nomura Adjusts Akeso's Price Target to HK$112.73 From HK$120.64, Keeps at Neutral	MT
16/25/16	HARMONi-6 Phase III Study of Ivonescimab Accepted by the Lancet and Selected for ESM0 2025 LBA Presentation	CI
31/25/31	Correction: Jefferies Adjusts Akeso's Price Target to HK$226 From HK$150, Keeps at Buy	MT
29/25/29	Jefferies Adjusts Akeso's Price Target to HK$150 From HK$226, Keeps at Buy	MT
18/25/18	Nomura Adjusts Akeso's Price Target to HK$120.64 From HK$99.66, Keeps at Neutral	MT
28/25/28	Nomura Downgrades Akeso to Neutral From Buy, Adjusts Price Target to HK$99.66 From HK$75.14	MT
18/25/18	Nomura Adjusts Akeso's Price Target to HK$75.14 From HK$66.40, Keeps at Buy	MT
11/24/11	GF Securities Starts Akeso at Buy with HK$81.59 Price Target	MT
10/24/10	Nomura Adjusts Akeso's Price Target to HK$66.40 From HK$46.04, Keeps at Buy	MT
16/24/16	Nomura Adjusts Akeso's Price Target to HK$46.04 From HK$52.80, Keeps at Buy	MT
23/24/23	Nomura Adjusts Akeso’s Price Target to HK$52.80 From HK$48.84, Keeps at Buy	MT
26/23/26	Nomura Adjusts Akeso's Price Target to HK$48.84 From HK$50.14, Keeps at Buy	MT
23/23/23	Nomura Adjusts Akeso's Price Target to HK$50.14 From HK$46.04, Keeps at Buy	MT
07/22/07	Nomura Adjusts Akeso's Price Target to HK$46.04 From HK$31.54, Keeps at Buy	MT
24/22/24	Nomura Adjusts Akeso's Price Target to HK$31.54 From HK$35.81, Keeps at Buy	MT
08/22/08	UBS Adjusts Akeso’s Price Target to HK$26.68 From HK$29.60, Keeps at Buy	MT
05/22/05	UBS Adjusts Akeso’s Price Target to HK$29.60 From HK$32.40, Keeps at Buy	MT
01/22/01	Nomura Adjusts Akeso's Price Target to HK$35.81 From HK$53.66, Keeps at Buy	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	AKESO, INC.					+58.36%
	ARGENX SE					+37.03%
	WUXI APPTEC CO., LTD.					+46.5%
	INSMED INCORPORATED					+52.35%
	BIONTECH SE					+42.05%
	WUXI BIOLOGICS (CAYMAN) INC.					+30.59%
	GENMAB A/S					+30.97%
	SUMMIT THERAPEUTICS INC.					+94.72%
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.					+36%
	EXELIXIS, INC.					+13.56%
	Average					+44.21%
	Weighted average by Cap.					+43.78%

See all sector consensus

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

23

Last Close Price

97.08CNY

Average target price

153.88CNY

Spread / Average Target

+58.50%

High Price Target

207.33CNY

Spread / Highest target

+113.56%

Low Price Target

99.67CNY

Spread / Lowest Target

+2.66%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Nomura
Jefferies & Co.
GF Securities
UBS

Ratings

Trader

Investor

Global

Quality

ESG MSCI

B

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

23

Last Close Price

97.08CNY

Average target price

153.88CNY

Spread / Average Target

+58.50%

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Stock Market
Equities
9926 Stock
Consensus Akeso, Inc.

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!

BENEFIT NOW